Abstract:Fungi and their natural products, like secondary metabolites, have gained a huge demand in the last decade due to their increasing applications in healthcare, environmental cleanup, and biotechnology-based industries. The fungi produce these secondary metabolites (SMs) during the different phases of their growth, which are categorized into terpenoids, alkaloids, polyketides, and non-ribosomal peptides. These SMs exhibit significant biological activity, which contributes to the formulation of novel pharmaceuticals, biopesticides, and environmental bioremediation agents. Nowadays, these fungal-derived SMs are widely used in food and beverages, for fermentation, preservatives, protein sources, and in dairy industries. In healthcare, it is being used as an antimicrobial, anticancer, anti-inflammatory, and immunosuppressive drug. The usage of modern tools of biotechnology can achieve an increase in demand for these SMs and large-scale production. The present review comprehensively analyses the diversity of fungal SMs along with their emerging applications in healthcare, agriculture, environmental sustainability, and nutraceuticals. Here, the authors have reviewed the recent advancements in genetic engineering, metabolic pathway manipulation, and synthetic biology to improve the production and yield of these SMs. Advancement in fermentation techniques, bioprocessing, and co-cultivation approaches for large-scale production of SMs. Investigators further highlighted the importance of omics technologies in understanding the regulation and biosynthesis of SMs, which offers an understanding of novel applications in drug discovery and sustainable agriculture. Finally, the authors have addressed the potential for genetic manipulation and biotechnological innovations for further exploitation of fungal SMs for commercial and environmental benefits.

Up-regulation of gut-enriched krüppel-like factor by interferon-gamma in human colon carcinoma cells.

Advances and Challenges in CRISPR/Cas-Based Fungal Genome Engineering for Secondary Metabolite Production: A Review

Applications of CRISPR/Cas9 in the Synthesis of Secondary Metabolites in Filamentous Fungi

Engineering fungal secondary metabolism: a roadmap to novel compounds.

CRISPR/Cas 9-Based Editing in the Production of Bioactive Molecules

The CRISPR/Cas9 System for Targeted Genome Engineering in Free-Living Fungi: Advances and Opportunities for Lichenized Fungi

CRISPR-aided genome engineering for secondary metabolite biosynthesis in Streptomyces

Strategies for gene disruption and expression in filamentous fungi

A Comprehensive Review of the Diversity of Fungal Secondary Metabolites and Their Emerging Applications in Healthcare and Environment

Integration of CRISPR/Cas9 with multi-omics technologies to engineer secondary metabolite productions in medicinal plant: Challenges and Prospects

Progress in endophytic fungi secondary metabolites: biosynthetic gene cluster reactivation and advances in metabolomics

Metabolic engineering of plant secondary metabolites: prospects and its technological challenges

A review: CRISPR/Cas12-mediated genome editing in fungal cells: advancements, mechanisms, and future directions in plant-fungal pathology

Utilization of CRISPR-Cas genome editing technology in filamentous fungi: function and advancement potentiality

CRISPR/Cas9-Based Genome Editing as a Way Ahead for Inducing Production of Bioactive Metabolites in Endophytes

Recent Trends and Advancements in CRISPR-Based Tools for Enhancing Resistance against Plant Pathogens.

Fungal secondary metabolism: regulation, function and drug discovery

Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria

Applications of CRISPR/Cas gene-editing technology in yeast and fungi

Application of CRISPR/Cas System in the Metabolic Engineering of Small Molecules

Translating biosynthetic gene clusters into fungal armor and weaponry